|
May 11
|
ANI Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
|
|
May 10
|
ANI Pharmaceuticals Reports Strong Q1 2024 Results, Surpassing Revenue Expectations
|
|
May 10
|
Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
|
|
May 10
|
Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
|
|
May 10
|
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
|
|
May 10
|
Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
|
|
May 10
|
ANI (ANIP) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
May 10
|
Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
|
|
May 10
|
ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance
|
|
May 9
|
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
|
|
May 9
|
Why Earnings Season Could Be Great for ANI Pharmaceuticals (ANIP)
|
|
May 9
|
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
|
|
May 9
|
Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss
|
|
May 8
|
Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues
|
|
May 8
|
Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates
|
|
May 8
|
Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues
|
|
May 7
|
Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil
|
|
May 7
|
Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
|
|
May 6
|
ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What's in Store?
|
|
May 3
|
Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
|